VALDIFF M 500 (Metformin (500mg) + Vildagliptin (50mg))
-15%

VALDIFF M 500 (Metformin (500mg) + Vildagliptin (50mg))

Original price was: ₹163.00.Current price is: ₹139.12.

Placeholder

Original price was: ₹163.00.Current price is: ₹139.12.

Add to cart
Buy Now
Category: Tag:

Valdiff-M 500 Tablet is formulated as a combination therapy to manage elevated blood sugar levels in individuals diagnosed with type 2 diabetes mellitus. This medication plays a crucial role in reducing the risk of serious diabetes-related complications, including kidney impairment and vision loss. It may also help lower the likelihood of experiencing cardiovascular events, such as heart attacks or strokes. The tablet can be utilized either as a standalone treatment or in conjunction with other antidiabetic medications. The effectiveness of all diabetes treatments is significantly enhanced when accompanied by a nutritious diet and consistent physical activity. Your healthcare provider will determine the appropriate dosage based on your specific medical condition, current blood glucose readings, and any other medications you may be taking. To minimize gastrointestinal discomfort, it is advisable to take this medication with meals. Consistency is key; therefore, it is important to take the tablet at the same time each day to maximize its benefits. Discontinuation should only occur upon your physician’s advice. This medication helps regulate blood sugar levels effectively and reduces the chances of future complications. Maintaining a healthy lifestyle is essential for effective diabetes management. Use this medicine only under medical supervision. Follow the dose and schedule exactly as advised. Do not stop abruptly without guidance. Keep a record of any unusual symptoms and share them with your clinician. Combine therapy with appropriate lifestyle measures and routine monitoring as recommended.

Reviews

There are no reviews yet.

Be the first to review “VALDIFF M 500 (Metformin (500mg) + Vildagliptin (50mg))”

Your email address will not be published. Required fields are marked *

Top